- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
A reflection on two decades of metabolomic innovations in capillary electrophoresis-mass spectrometry at the Institute for Advanced Biosciences, Keio University
Bibliographic Information
- Other Title
-
- Metaboromikusu no gijutsu kakushin ni taisuru Keiō gijuku daigaku sentan seimei kagaku kenkyūjo no 20nen ni wataru kōken
Search this article
Description
type:text
The Institute for Advanced Biosciences (IAB) at Keio University was first established in April 2001 to become a leading international metabolomics center for advancing integrated systems biology research. Unlike other metabolomic centers worldwide, IAB strategically focused on developing capillary electrophoresis-mass spectrometry (CE-MS) technology as their central instrumental platform for comprehensive analysis of polar/ionic metabolites in conjunction with bioinformatic tools for biomarker discovery and biochemical interpretation. In addition to hosting two International Metabolomics Society conferences, training young scientists and founding successful spin-off companies, IAB has contributed to high impact metabolomic studies as applied to clinical medicine, functional genomics and multi-omic studies, cancer diagnostic testing, agriculture and food science, as well as epidemiology and population health. IAB has also fostered metabolomic partnerships with the local community, clinicians and industry as reflected by their involvement in a prospective study of community-dwelling residents from Tsuruoka City and assessment of the quality of foods produced from the Shonai area. IAB has also spearheaded numerous CE-MS based metabolomic research collaborations elsewhere across Japan and worldwide. This short review will strive to highlight key milestones spanning over 20 years of research innovations in CE-MS metabolomics technology brought forth under the leadership of Dr. Masaru Tomita.
特集 SFCバイオの軌跡 第1章 先端生命科学 招待論文 : 総説・レビュー論文
Journal
-
- Keio SFC journal
-
Keio SFC journal 22 (2), 24-41, 2022
慶應SFC学会
- Tweet
Details 詳細情報について
-
- CRID
- 1390859370684389760
-
- ISSN
- 13472828
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- IRDB